Philip Morris International Inc. raised its 2026 full-year reported diluted EPS forecast to $7.28–$7.43, reflecting currency-only impacts. Excluding a total adjustment of $1.07 per share, the adjusted diluted EPS range is $8.35–$8.50, representing projected growth of 10.7% to 12.7% versus 2025. At prevailing exchange rates, excluding a favorable currency impact of $0.24 per share, this indicates underlying growth of 7.5% to 9.5%. The company also updated its Q3 adjusted diluted EPS forecast for currency only to $2.29–$2.34, now including an estimated 1 cent favorable currency impact compared to a previously reported unfavorable 8 cents. All other forecast assumptions remain unchanged from those communicated on July 22, 2026. Philip Morris International Inc. is a global consumer goods company that manufactures and sells tobacco products, including cigarettes and smoke-free alternatives like heat-not-burn devices and nicotine pouches.

Philip Morris International announced a contract manufacturing arrangement for combustible cigarettes with Philip Morris USA, an operating company of Altria Group Inc. The collaboration leverages the respective manufacturing capabilities of both organizations while PMI continues to focus on delivering a smoke-free future. First shipments are expected to begin early in 2027, subject to operational readiness and regulatory requirements. PMI stated it does not expect a material impact from this arrangement on its 2026 financials and confirmed that the company has no plans to commercialize combustible cigarettes in the United States. Philip Morris International is a global consumer goods company specializing in smoke-free products and tobacco.

Philip Morris International reported second-quarter 2026 net revenues of $11.2 billion, a 10.4% increase, with adjusted diluted EPS growing 15.2% to $2.20. Reported diluted EPS declined 7.7% to $1.80, primarily due to a $511 million non-cash impairment charge related to its RBH equity investment. The company updated its full-year 2026 adjusted diluted EPS forecast to a range of $8.11 to $8.26 excluding currency, representing a 7.5% to 9.5% increase over 2025. Smoke-free products now account for 42% of total net revenues. The company also noted that the FDA granted MRTP authorization to 20 ZYN nicotine pouch variants on June 30, 2026. Philip Morris International is a consumer goods company that manufactures cigarettes and smoke-free nicotine products.

Philip Morris International Inc. announced the appointment of Massimo Andolina to Group Chief Financial Officer, effective August 1, 2026, replacing Emmanuel Babeau. Mr. Babeau will transition to a Strategic Advisor to Group CEO Jacek Olczak through March 31, 2027. The separation agreement includes a lump sum severance payment of $1,563,423 and an additional $488,570 in lieu of his 2027 annual cash incentive compensation award, alongside full vesting of outstanding equity awards. Philip Morris International Inc. is a consumer goods company specializing in tobacco products.

On June 29, 2026, Philip Morris International Inc. prepaid €1.0 billion (approximately $1.1 billion) of the outstanding principal and accrued interest under the 5-year tranche of its senior unsecured term loan facility dated June 23, 2022. Following this prepayment, €1.5 billion (approximately $1.7 billion) remains outstanding under this tranche, which expires on June 23, 2027. The company operates in the tobacco industry and manufactures and sells cigarettes and smoke-free nicotine products.